Tyrosine
- Generic Name
- Tyrosine
- Brand Names
- Premasol, Clinimix E 2.75/5, Aminosyn-PF 7%, Primene, Clinimix 2.75/5, Trophamine 10 %, Plenamine, Olimel, Prosol, Clinisol 15, Periolimel, Travasol 10
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11NO3
- CAS Number
- 60-18-4
- Unique Ingredient Identifier
- 42HK56048U
Overview
Tyrosine is a non-essential amino acid. In animals it is synthesized from phenylalanine. It is also the precursor of epinephrine, thyroid hormones, and melanin.
Background
Tyrosine is a non-essential amino acid. In animals it is synthesized from phenylalanine. It is also the precursor of epinephrine, thyroid hormones, and melanin.
Indication
Tyrosine is claimed to act as an effective antidepressant, however results are mixed. Tyrosine has also been claimed to reduce stress and combat narcolepsy and chronic fatigue, however these claims have been refuted by some studies.
Associated Conditions
- Acute Renal Dysfunction
- Renal Failure, Chronic Renal Failure
Clinical Trials
FDA Approved Products
CLINIMIX E
Manufacturer:Baxter Healthcare Company
Route:INTRAVENOUS
Strength:32 mg in 100 mL
Approved: 2020/09/21
NDC:0338-0214
CLINIMIX
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:24 mg in 100 mL
Approved: 2021/04/13
NDC:0338-0198
ProSol
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:50 mg in 100 mL
Approved: 2020/10/07
NDC:0338-0499
Travasol
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:40 mg in 100 mL
Approved: 2017/11/16
NDC:0338-0644
Clinisol
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:39 mg in 100 mL
Approved: 2018/06/01
NDC:0338-0502
Singapore Approved Products
OLICLINOMEL N7-1000 E EMULSION FOR INFUSION
Manufacturer:BAXTER SA, Ajinomoto North America Incorporated (Intermediate)
Form:EMULSION
Strength:0.16 g/l
Online:Yes
Approved: 2004/05/06
Approval:SIN12539P
AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION
Manufacturer:B. Braun Melsungen AG
Form:INFUSION, SOLUTION
Strength:0.40g/1000ml
Online:Yes
Approved: 2018/01/23
Approval:SIN15411P
SmofKabiven Peripheral Emulsion for Infusion
Manufacturer:Fresenius Kabi AB
Form:INJECTION, EMULSION
Strength:0.4g /1000ml
Online:Yes
Approved: 2013/01/08
Approval:SIN14287P
VAMINOLACT INTRAVENOUS SOLUTION
Manufacturer:FRESENIUS KABI AUSTRIA GMBH
Form:INJECTION
Strength:500 mg/1000 ml
Online:Yes
Approved: 1993/05/12
Approval:SIN07428P
SmofKabiven Emulsion for Infusion
Manufacturer:Fresenius Kabi AB, Fresenius Kabi Austria GmbH
Form:INJECTION, EMULSION
Strength:0.4g /1000ml
Online:Yes
Approved: 2013/01/08
Approval:SIN14286P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath